Article actualité
Les articles d'actualités, brèves, dépêches et news du moment.
Les articles plus construits doivent aller dans la section "Dossiers".
Écrit par WHO
|
16 Juillet 2012
GENEVA ¦ 12 July 2012 – Children with disabilities are almost four times more likely to experience violence than non-disabled children, according to a review commissioned by the World Health Organization (WHO) and published today in the medical journal The Lancet.
Findings from the review indicate that children with disabilities are: 3.7 times more likely than non-disabled children to...
Écrit par WHO
|
16 Juillet 2012
LONDON/GENEVA |11 July 2012 – The World Health Organization (WHO) today committed to fast-track its assessment of new and existing quality contraceptives so more women in low- and middle-income countries can obtain and use a broader range of safe and effective contraceptive products.
Other pledges made by WHO at today’s Family Planning Summit in London include support to countries to...
Écrit par Ministère de la Santé
|
13 Juillet 2012
Agenda de Marisol Touraine Ministre des Affaires sociales et de la Santé Semaine du 16 juillet 2012
Lundi 16 juillet
07h35 Invitée de la matinale de LCI
1 Quai-du-Point-du-jour – 92565 Boulogne-Billancourt
11h00 Entretien avec Frédéric VAN ROEKEGHEM, Directeur général de la Caisse Nationale d'Assurance Maladie (CNAM)
Ministère des Affaires sociales et de la Santé – 14...
Écrit par GBI
|
16 Juillet 2012
NEW YORK (GBI Research), 13 July 2012 - Biobetters, drugs that have been improved since their initial incarnations, are demonstrating fantastic growth and leaving their originators well behind, states new research by pharmaceutical business specialists GBI Research.
The new report* explains how the more advanced drugs are far outstripping their biologic predecessors in terms of sales and...
Écrit par Quadro
|
13 Juillet 2012
The Quadro Ytron® HV-Emulsifier Group Seri
Waterloo, Canada, July 11, 2012 - Size Reduction or Milling of APIs (Active Pharmaceutical Ingredients) is a key step in the drug development process. When milling an API, the developer requires a tight particle size distribution that ensures consistent drug substance and drug product quality. Traditionally, dry milling technologies such as...
